WASHINGTON (dpa-AFX) - Myriad Genetics Inc. (MYGN) released Loss for first quarter that decreased from the same period last year but missed the Street estimates.
The company's bottom line came in at -$20.5 million, or -$0.26 per share. This compares with -$39.5 million, or -$0.52 per share, in last year's first quarter.
Excluding items, Myriad Genetics Inc. reported adjusted earnings of -$2.8 million or -$0.03 per share for the period.
Analysts on average had expected the company to earn -$0.07 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter fell 4.7% to $164.9 million from $173.1 million last year.
Myriad Genetics Inc. earnings at a glance (GAAP) :
-Earnings (Q1): -$20.5 Mln. vs. -$39.5 Mln. last year. -EPS (Q1): -$0.26 vs. -$0.52 last year. -Analyst Estimates: -$0.07 -Revenue (Q1): $164.9 Mln vs. $173.1 Mln last year.
-Guidance: Full year EPS guidance: Adj: $0.00 - $0.20 Full year revenue guidance: $670 - $700 Mln
Copyright(c) 2022 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
MYRIAD GENETICS-Aktie komplett kostenlos handeln - auf Smartbroker.de